You just read:

Ibrutinib RESONATE™ Data Show Significant Improvements in Progression-Free Survival and Overall Survival in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

News provided by

Janssen

31 May, 2014, 12:31 BST